The addition of evolocumab vs ezetimibe to statin therapy for coronary plaque regression and sd-LDL reduction in patients&#160;with&#160;ultrahigh-risk ASCVD.

Repatha (evolocumab) - Amgen, Astellas

ezetimibe - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42624727

Lin Yang; Na Ta; Xiao Zhou; Xiaoping Li; Yanxia Liu; Yimeng Zhang

Aug 21, 2026